diethylcarbamazine has been researched along with piriprost in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bach, MK; Brashler, JR | 2 |
Brahmi, Z; Bray, RA | 1 |
Morganroth, ML; Murphy, RC; Reeves, JT; Voelkel, NF | 1 |
4 other study(ies) available for diethylcarbamazine and piriprost
Article | Year |
---|---|
Studies with inhibitors of sulfidopeptide leukotriene synthesis.
Topics: Animals; Arachidonic Acids; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Glutathione Transferase; Humans; Kinetics; Leukotriene A4; Lipoxygenase Inhibitors; SRS-A; Sulfasalazine | 1985 |
Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor.
Topics: Animals; Arachidonate Lipoxygenases; Arachidonic Acids; Basophils; Cell Line; Diethylcarbamazine; Drug Synergism; Epoprostenol; Glutathione Transferase; Kinetics; Leukotriene A4; Lipoxygenase Inhibitors; Rats; SRS-A | 1986 |
Role of lipoxygenation in human natural killer cell activation.
Topics: Arachidonic Acid; Arachidonic Acids; Cytotoxicity, Immunologic; Diethylcarbamazine; Epoprostenol; Humans; Immunosuppressive Agents; Killer Cells, Natural; Kinetics; Leukotrienes; Lipoxygenase; Lipoxygenase Inhibitors; Lymphocyte Activation | 1986 |
Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction.
Topics: Angiotensin II; Animals; Chromones; Diethylcarbamazine; Epoprostenol; Male; Meclofenamic Acid; Oxygen; Potassium Chloride; Pulmonary Circulation; Rats; Rats, Inbred Strains; SRS-A; Vasoconstriction; Verapamil | 1984 |